Burning Rock Biotech Cash Flow Statement (2019-2025) | BNR

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-26.44M-31.02M-26.22M-39.77M-41.18M-39.73M-32.54M-30.80M-26.96M-18.61M-24.07M-22.55M-16.79M-14.87M-5.04M-9.68M-1.80M-1.27M-2.28M-1.95M
Share-based Compensation (Quarter)
13.08M12.91M8.28M9.50M12.63M11.70M11.38M12.89M11.43M5.40M10.15M9.91M9.70M9.41M1.41M1.12M0.63M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
-4.81M
Cash from Operations (Quarter)
-17.27M-18.43M-20.70M-17.63M-22.77M-16.32M-19.04M-9.52M-16.48M-10.92M-6.50M-2.26M-5.57M-5.62M-15.86M2.61M-3.24M-9.47M2.30M3.29M
Investing Activities
Cash from Investing Activities (Quarter)
44.01M-10.46M-11.18M-10.51M-2.05M4.59M-2.83M-0.73M-0.59M-0.40M-0.27M-0.05M-0.33M-0.03M-0.51M-0.11M-0.21M-0.18M-0.39M-0.05M
Financing Activities
Cash from Financing Activities (Quarter)
-0.64M-1.39M-5.12M-1.06M-0.62M-10.38M-0.38M-12.50M-0.01M-0.14M-6.29M-0.27M-0.01M279.06-0.01M0.28M-0.01M
Additional items
Exchange Rate Effect (Quarter)
2.15M-5.28M0.76M-3.88M-0.48M4.51M2.90M-0.84M-0.71M1.83M-0.27M-0.46M0.08M0.13M-0.50M0.82M-0.01M-0.03M-0.24M-1.22M
Change in Cash (Quarter)
28.95M-35.54M-36.10M-76.03M-25.91M-18.19M-19.55M-74.50M-17.78M-9.63M-13.23M-3.03M-5.89M-5.45M-16.67M3.28M-9.37M1.68M2.02M
Beginning Cash Balance (Quarter)
293.84M327.24M292.28M258.87M227.01M190.33M162.09M208.65M134.73M110.76M100.50M89.68M85.21M78.80M87.67M68.26M71.95M72.89M63.92M66.78M
Free Cash Flow (Quarter)
-17.45M-18.42M-20.62M-17.63M-22.75M-16.57M-19.04M-9.52M-16.54M-11.31M-33.15M-2.26M-5.57M-11.20M-15.86M2.61M-3.24M-9.38M2.29M3.29M
Net Cash Flow (Quarter)
26.38M-30.26M-36.86M-29.20M-25.42M-22.46M-22.25M-22.75M-17.14M-11.87M-40.87M-2.57M-5.91M-11.56M-16.38M2.49M-3.45M-9.29M1.91M3.23M